trial · primary record
TAK-788
Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
| Phase | Phase 3 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 354 |
| Primary completion | 2026-09-22 |
| Primary endpoint | Progression Free Survival (PFS) as Assessed by Blinded Independent Review Committee (IRC) per Response Evaluation Criteria in Solid Tumors (RECIST) Version 1.1 |
| Registry ID | NCT04129502 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:27:17.605Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04129502
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.